Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 7.18% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.3% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNDM
4176
Nano Dimension
NNDM
$325M
| $478K | ﹤0.01% |
+52,574
| New | +$267K |
|
4177
TriMas Corp
TRS
$1.43B
| $477K | ﹤0.01% |
15,056
-7,246
| -32% | -$198K |
|
|
PRO
4178
DELISTED
PROS Holdings
PRO
| $476K | ﹤0.01% |
9,368
-43,562
| -82% | -$1.72M |
|
|
MCFE
4179
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $475K | ﹤0.01% |
+28,437
| New | +$470K |
|
4180
InfuSystem Holdings
INFU
$239M
| $474K | ﹤0.01% |
25,224
-21,994
| -47% | -$331K |
|
4181
Aprea Therapeutics
APRE
$12M
| $473K | ﹤0.01% |
4,811
+3,803
| +377% | +$1.81M |
|
4182
CALL
CBRE Group
CBRE
$43.9B
| $470K | ﹤0.01% |
+7,500
| New | +$424K |
|
|
JTD
4183
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $469K | ﹤0.01% |
+32,971
| New | +$439K |
|
|
RADA
4184
DELISTED
Rada Electronic Industries Ltd
RADA
| $467K | ﹤0.01% |
+47,915
| New | +$368K |
|
|
TRUE
4185
DELISTED
TrueCar
TRUE
| $466K | ﹤0.01% |
110,859
-98,664
| -47% | -$440K |
|
|
DHF
4186
BNY Mellon High Yield Strategies Fund
DHF
$173M
| $465K | ﹤0.01% |
155,115
+23,436
| +18% | +$67K |
|
4187
Choiceone Financial
COFS
$497M
| $464K | ﹤0.01% |
15,063
-16,718
| -53% | -$501K |
|
|
DVAX
4188
DELISTED
Dynavax Technologies
DVAX
| $464K | ﹤0.01% |
104,164
-1,013,187
| -91% | -$4.59M |
|
4189
PUT
Karyopharm Therapeutics
KPTI
$43.5M
| $464K | ﹤0.01% |
2,000
-647
| -24% | -$150K |
|
4190
iShares Core MSCI EAFE ETF
IEFA
$196B
| $463K | ﹤0.01% |
6,700
-11,862
| -64% | -$767K |
|
4191
Saratoga Investment
SAR
$296M
| $463K | ﹤0.01% |
22,187
+2,734
| +14% | +$54.8K |
|
|
FFBW
4192
DELISTED
FFBW, Inc. Common Stock
FFBW
| $463K | ﹤0.01% |
46,530
-10,226
| -18% | -$98.2K |
|
4193
iShares MSCI Thailand ETF
THD
$355M
| $462K | ﹤0.01% |
5,992
-31,496
| -84% | -$2.23M |
|
4194
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$10.3B
| $461K | ﹤0.01% |
+14,967
| New | +$460K |
|
|
NAGE
4195
Niagen Bioscience
NAGE
$259M
| $461K | ﹤0.01% |
95,955
-107,091
| -53% | -$522K |
|
4196
CALL
C.H. Robinson
CHRW
$16.8B
| $460K | ﹤0.01% |
4,900
-7,500
| -60% | -$715K |
|
|
4197
PUT
C.H. Robinson
CHRW
$16.8B
| $460K | ﹤0.01% |
+4,900
| New | +$467K |
|
|
CLLS
4198
CALL
Cellectis
CLLS
$344M
| $460K | ﹤0.01% |
+17,000
| New | +$381K |
|
4199
Protagonist Therapeutics
PTGX
$9.74B
| $459K | ﹤0.01% |
+22,766
| New | +$490K |
|
|
AIFU
4200
AIFU Inc
AIFU
$147M
| $459K | ﹤0.01% |
+95
| New | +$559K |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $41.4B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.